Publication | Open Access
Modulating the function of ABCB1: <i>in vitro</i> and <i>in vivo</i> characterization of sitravatinib, a tyrosine kinase inhibitor
35
Citations
36
References
2020
Year
The findings in this study suggest that the combination of sitrvatinib and substrate antineoplastic drugs of ABCB1 could attenuate the MDR mediated by the overexpression of ABCB1.
| Year | Citations | |
|---|---|---|
Page 1
Page 1